Drug Discovery World

MAY 6, 2024

Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. share of global pharma revenues, according to analysts Statistica 1. In 2022, the continent held a 22.4%

Drugs 147

Drugs Molecular Biology Science Clinical Trials 147

Drug Discovery World

JULY 2, 2024

So, in this way there is a cross fertilisation from the bigger companies to newer ones. Start-ups will also take drug candidates from the pharma companies that are not getting attention for one reason or another and develop those into viable commercial products.”

Science 147

Science Drugs Clinical Trials Licensing 147

Drug Discovery World

JANUARY 5, 2023

There is a real danger for companies simply reacting to the latest EMA mandates, such as the specifics of how data will look under the EU’s eventual implementation of Identification of Medicinal Products (IDMP), and the perceived ‘watering down’ of data-driven process requirements via the shift to Digital Application Dataset Integration (DADI).

Pharma Companies 130

Pharma Companies International Compliance Production 130

The Pharma Data

SEPTEMBER 22, 2020

Swiss pharma company to acquire biotech for $449m (€380m). Swiss pharma company Roche is set to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m).

Pharma Companies 52

Pharma Companies Small Molecule Pharmaceutical Companies Disease 52

Drug Discovery World

MAY 7, 2024

And it won’t be a quick move back into this market, by those big companies, but I think we need to keep pushing them.” The healthcare sector is trying to make it more appealing for pharma companies to develop antimicrobials.

Vaccine 147

Vaccine Pharmaceutical Companies Clinical Trials Trials 147

Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. Opportunities Originator pharma companies are developing more and more complex products these days.

Production 130

Production Pharma Companies Clinical Trials FDA 130

The Pharma Data

AUGUST 21, 2020

. Senior leaders in pharma and patient groups will be offering key insights into impactful patient centricity and advocacy at the Patient Partnership Index virtual conference on October 7. Places are limited, with priority being given to those working for pharmaceutical companies or patient groups.

Pharma Companies 52

Pharma Companies Pharmaceutical Companies Pharmaceuticals 52

The Pharma Data

APRIL 27, 2022

The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies. One of the major challenges for pharmaceutical executives is to manage the leveraging manufacturing and packaging processes.

Packaging 52

Packaging Pharmaceuticals Pharma Companies Pharmaceutical Companies 52

Drug Discovery World

SEPTEMBER 7, 2022

The drug discovery and development process is costly and arduous, offering no certainty of success which often rests on whether a company has chosen the correct drug molecule and target. Dr Arne Kusserow of Merck Group thinks the pandemic has absolutely had an effect on the AI sector. . Future trends .

Research 130

Research Clinical Trials Pharmaceutical Companies Pharma Companies 130

Drug Discovery World

FEBRUARY 10, 2023

“We have 3,000 companies in the life sciences sector. A good part of half of those are within pharma. The weakness connected to that is we have so few large pharmaceuticals. It now has over 300 Swedish and Danish members from across academia, life sciences parks and pharmaceutical companies.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

H1 Blog

NOVEMBER 15, 2023

Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game. Compliance ensures that interactions between pharmaceutical companies and KOLs are transparent, fair, and free from any undue influence.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

The Open Targets Blog

OCTOBER 24, 2023

  A significant challenge for biotech and pharmaceutical companies is to make sense of the signals coming from genome-wide association studies (GWAS), most of which are in the non-coding part of the genome. We released the package on my personal GitHub so that I could keep updating it in the future.

Bioinformatics 64

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 64

Drug Discovery World

NOVEMBER 15, 2022

If a pharmaceutical company is racing to identify a new vaccine, for instance, then waiting for three weeks to receive DNA sequences each time can slow down the development process compared to competitors who might have faster timelines.” . The longer the DNA gets, the longer it will take for labs to receive it,” notes Dr Daniels.

DNA 246

DNA Engineering Drugs Vaccine 246

Alta Sciences

MARCH 27, 2024

At this same time, a large pharmaceutical company invited our graduating class to a retreat where they introduced us to their different departments. While I enjoyed data collection, it was writing my thesis in which complex data was described and interpreted that really invigorated me.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

Predictive Oncology

FEBRUARY 7, 2023

Because pharma companies can’t predict which early-stage drug candidates will succeed, they end up playing a “numbers game,” according to Bush, by advancing multiple compounds. What happens if we are able to provide information to the pharmaceutical company that doubles that [and] one in 10 molecules actually make it?”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Drug Discovery World

NOVEMBER 16, 2022

Here, DDW’s Reece Armstrong speaks to Dan O’Connor, VP of drug discovery at Molecular Devices, about what the OIC offers to pharmaceutical companies and the advantages and barriers of 3D biology. . 2D biology has been used by pharmaceutical researchers for decades. 2D vs 3D .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

Drug Discovery World

OCTOBER 16, 2023

Despite the overall reduction in major pharma R&D centres in the UK, global pharma companies continue to engage with academic and biotech organisations here, particularly in hotspots such as the Golden Triangle, the Northwest, and Scotland, through the strong networks that have been developed between these organisations.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Eye on FDA

JANUARY 9, 2022

As noted in the past, there are two primary means for understanding the agency’s latest thinking with respect to promotional communications from pharmaceutical companies – the content and pattern of enforcement and the issuance of guidance documents to shed light on the parameters that exist. Why This is a Fail.

FDA 64

FDA Pharma Companies Pharmaceutical Companies Production 64

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools?

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. What is a value-added medicine?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Production 52

Drug Discovery World

JANUARY 26, 2023

However, coming off the back of high levels of return on investment (ROI) seen throughout Covid-19 and therefore 2021, was always going to be difficult for the pharma industry. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

The Pharma Data

DECEMBER 11, 2020

SeaCube Containers , a pharmaceutical cargo trade company, has acquired 200 storage containers developed by Carrier and Sensitech to help address the anticipated increase in demand for refrigerated storage capacity and cargo visibility in support of Covid-19 vaccine distribution.

Vaccine 52

Vaccine Immune Response Pharma Companies Virus 52

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose.

Virus 52

Virus Vaccine International Immune Response 52

Drug Target Review

APRIL 19, 2024

We also have collaborations with pharmaceutical companies where we leverage the best of our unique platform and pharma expertise on the target. Our technology is designed to be applicable to every therapeutic area, including oncology and neurodegeneration. My STEM story today is different from where it started.

Molecular Biology 110

Molecular Biology Small Molecule Pharmaceuticals Research 110

Drug Discovery World

SEPTEMBER 29, 2022

For these reasons and others, many biotech and pharmaceutical companies – along with government research labs and academic institutions – rely on contract research organizations (CROs) for drug discovery services. Big pharma companies routinely maintain their own decks of upwards of millions of compounds.

Small Molecule 130

Small Molecule Assay Development DNA Biochemical Assays 130

H1 Blog

MARCH 27, 2023

As the primary interface between healthcare providers (HCPs) and pharmaceutical companies, medical science liaisons (MSLs) have a unique opportunity to engage with HCPs in clinical discussions and bridge care gaps by providing crucial insights into evidence-based medicine.

Science 52

Science Pharma Companies Pharmaceutical Companies Treatment 52

Drug Target Review

MAY 23, 2023

Pharmaceutical companies meanwhile need to reinvest in natural product research. Exploring this unexploited resource through revived natural product research represents a new avenue for pharma companies to take on the challenges of IBD and other diseases.

Small Molecule 75

Small Molecule Drugs Production Pharma Companies 75

Drug Discovery World

AUGUST 23, 2023

An internal analysis at a top 10 pharmaceutical company showed that in preclinical studies alone, this kind of ‘dark data’ was costing its business $20 million a year in delays, compliance challenges, and missed operational insights.

Compliance 130

Compliance Laboratories Science Pharma Companies 130

The Pharma Data

NOVEMBER 11, 2020

We are honored to partner with Taiho, a Japanese pharmaceutical company with a commitment to the respiratory field, for the development and commercialization of LTI-01 in Japan. About Taiho Pharmaceutical Co., Taiho Pharmaceutical, a subsidiary of Otsuka Holdings Co., For more information, visit lungtx.com.

Licensing 40

Licensing Licensing Treatment Pharma Companies 40

Elrig

APRIL 29, 2024

Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

The Pharma Data

DECEMBER 23, 2020

is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus. See: PLOS ONE ). AIM CEO Thomas K. If successful, this may change millions of lives for the better.”.

Clinical Trials 52

Clinical Trials Trials Virus International 52

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. Talking Medicine uses advanced AI to provide pharmaceutical companies with real-time data intelligence. Growth Programme. Dolmatics – U.K.-based

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals DNA 52

Advarra

JULY 19, 2022

The sponsor is the pharmaceutical company conducting the trial. A: Working in a pharmaceutical company is the best way to learn this. Each company will have its own processes, but they will all have the same result. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval.

Packaging 52

Packaging FDA Regulations Trials 52

Drug Discovery World

AUGUST 16, 2022

In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. Educational institutes and pharmaceutical companies, too, are contributing to scholarships, fellowships, and training opportunities for underserved groups. “At

Research 130

Research Clinical Trials Trials Drug Development 130

The Pharma Data

DECEMBER 30, 2020

It also calls for ending the tax deductions that pharmaceutical companies can take for the amount of money it spends on advertising its medications. BioMarin Pharmaceutical’s Roctavian for hemophilia B. M&A.

Vaccine 52

Vaccine FDA Trials Therapies 52

Codon

FEBRUARY 13, 2024

3 Another considerable obstacle to pharmaceutical companies’ interest (and investment) is the fact that for a product to be patentable — and therefore profitable — it has to be considered new and inventive.

Therapies 138

Therapies DNA Virus Clinical Trials 138

Drug & Device Law

APRIL 7, 2023

The case is Vanda Pharmaceuticals, Inc. 27, 2023), and the plaintiff was a pharmaceutical company that wanted to know what the FDA really thought of its drug. The company lodged a request under the Freedom of Information Act (“FOIA”), which the FDA refused. 22-cv-938, 2023 U.S. LEXIS 51853 (D.D.C. Here is what happened.

FDA 64

FDA Government Pharma Companies Regulations 64